Medikit Co.,Ltd. (TYO:7749)

Market Cap	44.47B
Revenue (ttm)	23.19B
Net Income (ttm)	3.09B
Shares Out	14.63M
EPS (ttm)	210.70
PE Ratio	14.43
Forward PE	n/a
Dividend	100.00 (3.33%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,200
Average Volume	2,795
Open	3,000.00
Previous Close	2,999.00
Day's Range	2,990.00 - 3,040.00
52-Week Range	2,362.00 - 3,080.00
Beta	0.13
RSI	64.56
Earnings Date	Feb 12, 2026

About Medikit

Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, sells, and exports medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and infusions....

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1973
• Employees: 989
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7749

Financial Performance

In 2024, Medikit's revenue was 22.55 billion, an increase of 3.22% compared to the previous year's 21.85 billion. Earnings were 3.01 billion, a decrease of -1.82%.